Cas12蛋白全球市場報告（2025年）

近年來，Cas12蛋白的市場規模迅速擴張，預計將從2024年的19.5億美元成長到2025年的22.6億美元，複合年成長率達15.9%。預測期內的成長可歸因於政府對生物技術和基因工程舉措的投資增加、發展中地區對照護現場解決方案的需求不斷成長、Cas12系統與次世代定序平台的整合日益廣泛、人們對疾病早期檢測和預防策略的興趣日益濃厚，以及蛋白質工程技術的進步提高了Cas12的特異性。

預計未來幾年Cas12蛋白市場將快速成長，到2029年市場規模將達到40.3億美元，複合年成長率（CAGR）為15.5%。預測期內的成長主要歸因於遺傳疾病盛行率的上升、基因編輯研發投入的增加、個人化醫療意識的增強、對快速精準感染疾病診斷需求的成長，以及Cas12蛋白在農業生物技術中用於作物增產的廣泛應用。預測期內的關鍵趨勢包括與其他CRISPR組件的整合、基因編輯遞送技術的進步、修飾型Cas12蛋白的開發、診斷平台技術的改進以及生物資訊工具的進步。

Cas12蛋白是一種與成簇規律間隔短叢集重複序列（CRISPR）相關的酶，在基因編輯和分子診斷中發揮重要作用。在CRISPR RNA的引導下，Cas12能夠尋找並精確地切割特定的DNA序列。其額外的切割活性也使其可用於快速靈敏的診斷應用。

Cas12蛋白主要分為天然Cas12蛋白、工程化Cas12蛋白、與其他CRISPR組分整合的Cas12蛋白。天然Cas12蛋白是細菌酶，能夠辨識並切割特定的DNA序列，是CRISPR免疫防禦系統的一部分。這些蛋白質有多種製劑形式，包括液體、冷凍乾燥粉和質體衍生形式。常用的遞送方法包括病毒載體、脂質奈米顆粒、電穿孔和顯微注射。 Cas12蛋白廣泛應用於基因組編輯、基因敲除、基因調控、基因工程和治療藥物研發等領域，服務終端用戶包括學術和研究機構、製藥和生物技術公司、診斷實驗室以及農業企業等。

2025年，美國關稅的突然上調及其引發的貿易摩擦對製藥公司造成了嚴重衝擊。利潤率高的學名藥生產商尤其脆弱，一些公司不得不縮減低收益藥物的生產規模。生物技術公司也因關稅導致的專用試劑短缺而面臨臨床試驗延期。為因應這一局面，製藥業正在印度和歐洲擴大原料藥的生產，增加庫存，並遊說政府對基本藥物給予貿易豁免。

這份Cas12蛋白市場研究報告是商業研究公司最新系列報告的一部分，提供Cas12蛋白市場統計數據，例如全球市場規模、區域佔有率、佔據Cas12蛋白市場佔有率的競爭對手、詳細的Cas12蛋白市場細分、市場趨勢以及Cas12蛋白行業的商業機會。本市場研究報告對該行業的現狀和未來發展趨勢進行了詳細分析，為您提供所需的一切全面觀點。

預計未來幾年，遺傳疾病盛行率的上升將推動Cas12蛋白市場的成長。遺傳疾病是由個體DNA的突變或改變引起的，這些突變或改變會擾亂正常的身體功能。遺傳疾病發生率的上升與近親結婚率的上升密切相關，近親結婚會增加遺傳疾病的風險。 Cas12蛋白能夠精準靶向特定位點，切割DNA並糾正、移除或替換缺陷基因，從而實現針對遺傳疾病的精準基因治療，同時最大限度地減少脫靶效應。例如，英國國家醫療服務體系（NHS）在2024年5月報告稱，英格蘭約有17,000人患有鐮狀細胞貧血症（一種鐮狀血液疾病），每年新增病例約250例。因此，遺傳疾病盛行率的上升正在推動對Cas12蛋白市場的需求。

Cas12蛋白市場的主要企業正在採取策略性措施，例如股權投資，以加速創新並擴展其基因編輯能力。股權投資是指購買公司的股份或所有權，使投資者獲得部分所有權，並有可能根據公司的業績獲得回報。例如，2024年4月，美國生技公司Regeneron Pharmaceuticals向Mammoth Biosciences投資1億美元，利用Mammoth Biosciences的超小型CRISPR酶，透過腺結合病毒（AAV）在除肝臟以外的多種組織中進行體內基因編輯治療。透過將Mammoth Biosciences的超小型CRISPR酶與Regeneron先進的AAV遞送系統相結合，該合作實現了精準高效的體內基因編輯。這項合作將為Mammoth Biosciences提供資金、里程碑付款和特許權使用費，同時使Regeneron在五年多的時間裡獨家使用先進的基因編輯工具，從而加速開發針對更廣泛疾病的下一代基因藥物。

2023年8月，中國生技公司匯基生物科技有限公司與凱克生物技術有限公司達成合作，共同開發一種針對罕見遺傳疾病的新型基因編輯療法。此次合作旨在加速匯基高精度基因編輯酶hfCas12Max在大中華區的商業化和GMP生產，並將充分利用凱克生物技術在下一代基因組藥物開發方面的專業技術。凱克生物技術是一家專注於Cas12蛋白生產的中國公司。

Cas12蛋白市場包括分子診斷套件、科研試劑和生物感測器的銷售。該市場的價值為“出廠價”，即製造商或產品創造者向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的產品的價值。該市場的產品價值還包括產品創造者提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球Cas12蛋白：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
• 終端用戶產業分析
• 全球Cas12蛋白市場：成長率分析
• 全球Cas12蛋白市場表現：規模與成長，2019-2024年
• 全球Cas12蛋白市場預測：規模與成長，2024-2029年，2034年
• 全球 Cas12 蛋白：潛在市場規模 (TAM)

第6章 市場細分

• 全球Cas12蛋白市場按類型、性能和預測分類，2019-2024年、2024-2029年、2034年
• 天然Cas12蛋白
• 修飾的Cas12蛋白
• 與其他CRISPR組件的整合
• 全球Cas12蛋白市場：依配方、效能和預測分類，2019-2024年、2024-2029年和2034年
• 液體製劑
• 凍乾粉
• 質體衍生
• 全球Cas12蛋白市場依遞送方式分類：效能及預測，2019-2024年、2024-2029年、2034年
• 病毒載體
• 脂質奈米顆粒
• 電穿孔
• 顯微注射
• 全球Cas12蛋白市場：依應用、效能和預測分類，2019-2024年、2024-2029年、2034年
• 基因組編輯
• 基因敲除
• 基因調控
• 基因工程
• 治療藥物研發
• 全球Cas12蛋白市場依最終用戶、效能和預測分類，2019-2024年、2024-2029年、2034年
• 學術和研究機構
• 製藥和生物技術公司
• 診斷實驗室
• 農業企業
• 全球 Cas12 蛋白市場：天然 Cas12 蛋白細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
• Cas12a
• Cas12b
• Cas12c
• 全球Cas12蛋白市場：修飾型Cas12蛋白細分市場，按類型、性能和預測（2019-2024年、2024-2029年、2034年）
• 工程改造的Cas12變體
• 高保真Cas12蛋白
• Cas12融合蛋白
• 全球 Cas12 蛋白市場：與其他 CRISPR 組件整合細分市場，按類型分類，實際數據和預測數據，2019-2024 年、2024-2029 年、2034 年
• Cas12 和 Cas9 系統
• Cas12 和鹼基編輯器
• Cas12 與 Prime Editor

第7章 區域和國家分析

• 全球Cas12蛋白市場：按地區、表現和預測分類，2019-2024年、2024-2029年、2034年
• 全球Cas12蛋白市場：依國家、效能和預測分類，2019-2024年、2024-2029年、2034年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• Cas12蛋白市場：競爭格局
• Cas12蛋白市場：公司概況
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Integrated DNA Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • GenScript Biotech Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Takara Bio Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• Abcam plc
• Aldevron LLC
• New England Biolabs Inc.
• Cusabio Biotech Co. Ltd.
• Synthego Corporation
• ABclonal Technology Co. Ltd.
• Mammoth Biosciences Inc.
• Rockland Immunochemicals Inc.
• Creative BioMart
• Editas Medicine Inc.
• VectorBuilder
• Sherlock Biosciences
• Biomatik
• SBS Genetech Co. Ltd.
• ProSpec-Tany Technogene Ltd.

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

• Cas12蛋白市場展望2029：提供新機會的國家
• Cas12蛋白市場展望2029：新興細分市場蘊藏新的機會
• Cas12蛋白市場2029：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章附錄

Cas12 protein is an enzyme associated with clustered regularly interspaced short palindromic repeats (CRISPR) that plays a crucial role in gene editing and molecular diagnostics. Guided by CRISPR RNA, Cas12 locates specific DNA sequences and cleaves them precisely, allowing for targeted genetic modifications. Its collateral cleavage activity also makes it valuable for rapid and sensitive diagnostic applications.

The primary types of Cas12 protein include natural Cas12 proteins, modified Cas12 proteins, and those integrated with other CRISPR components. Natural Cas12 proteins are bacterial enzymes that identify and cut specific DNA sequences as part of the CRISPR immune defense system. These proteins are available in different formulations, such as liquid, lyophilized powder, and plasmid-derived forms. Common delivery methods include viral vectors, lipid nanoparticles, electroporation, and microinjection. Cas12 proteins are widely used in applications such as genome editing, gene knockout, gene regulation, genetic engineering, and therapeutic development, serving end users including academic and research institutions, pharmaceutical and biotechnology companies, diagnostic laboratories, and agricultural organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The Cas12 protein market research report is one of a series of new reports from The Business Research Company that provides Cas12 protein market statistics, including Cas12 protein industry global market size, regional shares, competitors with a Cas12 protein market share, detailed Cas12 protein market segments, market trends and opportunities, and any further data you may need to thrive in the Cas12 protein industry. This Cas12 protein market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The Cas12 protein market size has grown rapidly in recent years. It will grow from $1.95 billion in 2024 to $2.26 billion in 2025 at a compound annual growth rate (CAGR) of 15.9%. The growth in the historic period can be attributed to rising government investments in biotechnology and genetic engineering initiatives, increasing demand for point-of-care diagnostic solutions in developing regions, expanding integration of Cas12 systems into next-generation sequencing platforms, heightened focus on early disease detection and prevention strategies, and advancing protein engineering techniques that improve Cas12 specificity.

The Cas12 protein market size is expected to see rapid growth in the next few years. It will grow to $4.03 billion in 2029 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to the rising prevalence of genetic disorders, increasing investment in gene-editing research and development, growing awareness of personalized medicine, higher demand for rapid and precise infectious disease diagnostics, and expanding use of Cas12 proteins in agricultural biotechnology for crop enhancement. Key trends in the forecast period include integration with other CRISPR components, advancements in gene-editing delivery technologies, development of modified Cas12 proteins, technological improvements in diagnostic platforms, and progress in bioinformatics tools.

The rising prevalence of genetic diseases is expected to drive the growth of the Cas12 protein market in the coming years. Genetic diseases are caused by mutations or changes in an individual's DNA that disrupt normal bodily functions. Their increasing incidence is linked to the rising rate of consanguineous marriages, which heightens the likelihood of inheriting genetic disorders. Cas12 proteins precisely target and cut DNA at specific sites to correct, remove, or replace faulty genes, enabling highly accurate gene therapies for inherited conditions with minimal off-target effects. For example, in May 2024, the National Health Service, a UK-based government department, reported that approximately 17,000 people in England live with sickle cell disease, an inherited blood disorder, with around 250 new cases diagnosed annually. Consequently, the growing prevalence of genetic diseases is fueling demand in the Cas12 protein market.

Key companies in the Cas12 protein market are adopting strategic approaches, such as equity investments, to accelerate innovation and expand gene-editing capabilities. Equity investment involves purchasing shares or ownership stakes in a company, giving investors partial ownership and potential returns based on company performance. For instance, in April 2024, Regeneron Pharmaceuticals, Inc., a US-based biotechnology company, invested $100 million in Mammoth Biosciences to access their ultracompact CRISPR enzymes for in vivo gene editing therapies using adeno-associated viruses (AAVs) across multiple tissues beyond the liver. By combining Mammoth's ultracompact CRISPR enzymes with Regeneron's advanced AAV delivery system, the partnership enables precise and efficient in vivo editing. This collaboration provides Mammoth with funding, milestones, and royalties, while Regeneron gains exclusive access to advanced gene-editing tools for over five years, collectively accelerating next-generation genetic medicines for a broader range of diseases.

In August 2023, Hui-Gene Therapeutics Co., Ltd., a China-based biotechnology company, partnered with Kactus Biotechnology to develop novel gene-editing therapies targeting rare genetic disorders. The collaboration aims to fast-track commercialization and GMP manufacturing of Hui-Gene's high-precision gene-editing enzyme hfCas12Max in Greater China, leveraging Kactus Bio's expertise to advance next-generation genome medicines. Kactus Biotechnology is a China-based company specializing in the production of Cas12 proteins.

Major players in the cas12 protein market are Thermo Fisher Scientific Inc., Bio-Techne Corporation, Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio Inc., Abcam plc, Aldevron LLC, New England Biolabs Inc., Cusabio Biotech Co. Ltd., Synthego Corporation, ABclonal Technology Co. Ltd., Mammoth Biosciences Inc., Rockland Immunochemicals Inc., Creative BioMart, Editas Medicine Inc., VectorBuilder, Sherlock Biosciences, Biomatik, SBS Genetech Co. Ltd., ProSpec-Tany Technogene Ltd., Inscripta Inc., Addgene Inc.

North America was the largest region in the Cas12 protein market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in Cas12 protein market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the Cas12 protein market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The Cas12 protein market consists of sales of molecular diagnostic kits, research reagents, and biosensors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cas12 Protein Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cas12 protein market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cas12 protein ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cas12 protein market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Natural Cas12 Proteins; Modified Cas12 Proteins; Integration With Other Crispr Components
• 2) By Formulation: Liquid Formulations; Lyophilized Powder; Plasmid-Derived Cas12 Proteins
• 3) By Delivery Method: Viral Vectors; Lipid Nanoparticles; Electroporation; Microinjection
• 4) By Application: Genome Editing; Gene Knockout; Gene Regulation; Genetic Engineering; Therapeutics Development
• 5) By End User: Academic And Research Institutes; Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories; Agricultural Companies
• Subsegments:
• 1) By Natural Cas12 Proteins: Cas12a; Cas12b; Cas12c
• 2) By Modified Cas12 Proteins: Engineered Cas12 Variants; High-Fidelity Cas12 Proteins; Fusion Proteins With Cas12
• 3) By Integration With Other CRISPR Components: Cas12 With Cas9 Systems; Cas12 With Base Editors; Cas12 With Prime Editors
• Companies Mentioned: Thermo Fisher Scientific Inc.; Bio-Techne Corporation; Integrated DNA Technologies Inc.; GenScript Biotech Corporation; Takara Bio Inc.; Abcam plc; Aldevron LLC; New England Biolabs Inc.; Cusabio Biotech Co. Ltd.; Synthego Corporation; ABclonal Technology Co. Ltd.; Mammoth Biosciences Inc.; Rockland Immunochemicals Inc.; Creative BioMart; Editas Medicine Inc.; VectorBuilder; Sherlock Biosciences; Biomatik; SBS Genetech Co. Ltd.; ProSpec-Tany Technogene Ltd.; Inscripta Inc.; Addgene Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cas12 Protein Market Characteristics

3. Cas12 Protein Market Trends And Strategies

4. Cas12 Protein Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cas12 Protein Growth Analysis And Strategic Analysis Framework

• 5.1. Global Cas12 Protein PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Cas12 Protein Market Growth Rate Analysis
• 5.4. Global Cas12 Protein Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Cas12 Protein Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Cas12 Protein Total Addressable Market (TAM)

6. Cas12 Protein Market Segmentation

• 6.1. Global Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Natural Cas12 Proteins
• Modified Cas12 Proteins
• Integration With Other Crispr Components
• 6.2. Global Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Liquid Formulations
• Lyophilized Powder
• Plasmid-Derived Cas12 Proteins
• 6.3. Global Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Viral Vectors
• Lipid Nanoparticles
• Electroporation
• Microinjection
• 6.4. Global Cas12 Protein Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Genome Editing
• Gene Knockout
• Gene Regulation
• Genetic Engineering
• Therapeutics Development
• 6.5. Global Cas12 Protein Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Academic And Research Institutes
• Pharmaceutical And Biotechnology Companies
• Diagnostic Laboratories
• Agricultural Companies
• 6.6. Global Cas12 Protein Market, Sub-Segmentation Of Natural Cas12 Proteins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cas12a
• Cas12b
• Cas12c
• 6.7. Global Cas12 Protein Market, Sub-Segmentation Of Modified Cas12 Proteins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Engineered Cas12 Variants
• High-Fidelity Cas12 Proteins
• Fusion Proteins With Cas12
• 6.8. Global Cas12 Protein Market, Sub-Segmentation Of Integration With Other CRISPR Components, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cas12 With Cas9 Systems
• Cas12 With Base Editors
• Cas12 With Prime Editors

7. Cas12 Protein Market Regional And Country Analysis

• 7.1. Global Cas12 Protein Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Cas12 Protein Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cas12 Protein Market

• 8.1. Asia-Pacific Cas12 Protein Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cas12 Protein Market

• 9.1. China Cas12 Protein Market Overview
• 9.2. China Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cas12 Protein Market

• 10.1. India Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cas12 Protein Market

• 11.1. Japan Cas12 Protein Market Overview
• 11.2. Japan Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cas12 Protein Market

• 12.1. Australia Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cas12 Protein Market

• 13.1. Indonesia Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cas12 Protein Market

• 14.1. South Korea Cas12 Protein Market Overview
• 14.2. South Korea Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cas12 Protein Market

• 15.1. Western Europe Cas12 Protein Market Overview
• 15.2. Western Europe Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cas12 Protein Market

• 16.1. UK Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cas12 Protein Market

• 17.1. Germany Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cas12 Protein Market

• 18.1. France Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cas12 Protein Market

• 19.1. Italy Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cas12 Protein Market

• 20.1. Spain Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cas12 Protein Market

• 21.1. Eastern Europe Cas12 Protein Market Overview
• 21.2. Eastern Europe Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cas12 Protein Market

• 22.1. Russia Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cas12 Protein Market

• 23.1. North America Cas12 Protein Market Overview
• 23.2. North America Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cas12 Protein Market

• 24.1. USA Cas12 Protein Market Overview
• 24.2. USA Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cas12 Protein Market

• 25.1. Canada Cas12 Protein Market Overview
• 25.2. Canada Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cas12 Protein Market

• 26.1. South America Cas12 Protein Market Overview
• 26.2. South America Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cas12 Protein Market

• 27.1. Brazil Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cas12 Protein Market

• 28.1. Middle East Cas12 Protein Market Overview
• 28.2. Middle East Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cas12 Protein Market

• 29.1. Africa Cas12 Protein Market Overview
• 29.2. Africa Cas12 Protein Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Cas12 Protein Market, Segmentation By Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Cas12 Protein Market, Segmentation By Delivery Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cas12 Protein Market Competitive Landscape And Company Profiles

• 30.1. Cas12 Protein Market Competitive Landscape
• 30.2. Cas12 Protein Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bio-Techne Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Integrated DNA Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GenScript Biotech Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Takara Bio Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cas12 Protein Market Other Major And Innovative Companies

• 31.1. Abcam plc
• 31.2. Aldevron LLC
• 31.3. New England Biolabs Inc.
• 31.4. Cusabio Biotech Co. Ltd.
• 31.5. Synthego Corporation
• 31.6. ABclonal Technology Co. Ltd.
• 31.7. Mammoth Biosciences Inc.
• 31.8. Rockland Immunochemicals Inc.
• 31.9. Creative BioMart
• 31.10. Editas Medicine Inc.
• 31.11. VectorBuilder
• 31.12. Sherlock Biosciences
• 31.13. Biomatik
• 31.14. SBS Genetech Co. Ltd.
• 31.15. ProSpec-Tany Technogene Ltd.

32. Global Cas12 Protein Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cas12 Protein Market

34. Recent Developments In The Cas12 Protein Market

35. Cas12 Protein Market High Potential Countries, Segments and Strategies

• 35.1 Cas12 Protein Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Cas12 Protein Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Cas12 Protein Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer